We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-8.74%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.03B
AUM Growth
-$97.2M
Cap. Flow
+$5.15M
Cap. Flow %
0.5%
Top 10 Hldgs %
54.98%
Holding
5,775
New
1,132
Increased
1,485
Reduced
1,487
Closed
1,545

Sector Composition

Rank Sector Weight
1 Financials 2.17%
2 Healthcare 1.69%
3 Industrials 1.67%
4 Technology 1.59%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEP
3176
DELISTED
Holly Energy Partners, L.P.
HEP
$3K ﹤0.01%
100
-1,645
-94% -$51.3K
ZYNE
3177
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$3K ﹤0.01%
+200
New +$4.91K
NYMX
3178
DELISTED
Nymox Pharmaceutical Corp
NYMX
$3K ﹤0.01%
739
-6,428
-90% -$15K
BLCM
3179
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$3K ﹤0.01%
23
-7
-23% -$1.28K
ABB
3180
DELISTED
ABB Ltd
ABB
$3K ﹤0.01%
179
-121
-40% -$2.36K
CYAD
3181
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$3K ﹤0.01%
62
-721
-92% -$37.1K
VYNT
3182
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$3K ﹤0.01%
+2
New +$3.06K
DS
3183
DELISTED
Drive Shack Inc.
DS
$3K ﹤0.01%
700
-10,008
-93% -$47.8K
HTGM
3184
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$3K ﹤0.01%
+2
New +$3.09K
BKEP
3185
DELISTED
Blueknight Energy Partners L.P.
BKEP
$3K ﹤0.01%
521
+483
+1,271% +$3.22K
EPZM
3186
DELISTED
Epizyme, Inc
EPZM
$3K ﹤0.01%
200
-1,663
-89% -$33.6K
PBIP
3187
DELISTED
Prudential Bancorp, Inc.
PBIP
$3K ﹤0.01%
+213
New +$3.1K
ZSAN
3188
DELISTED
Zosano Pharma Corporation
ZSAN
$3K ﹤0.01%
+1
New +$5.61K
FMO
3189
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$3K ﹤0.01%
+38
New +$3.76K
MMAC
3190
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$3K ﹤0.01%
202
-2,326
-92% -$30.2K
OTEL
3191
DELISTED
Otelco, Inc. Class A
OTEL
$3K ﹤0.01%
596
+186
+45% +$1.01K
TCCO
3192
DELISTED
Technical Communications Corporation
TCCO
$3K ﹤0.01%
1,073
+985
+1,119% +$3.16K
SCIX
3193
DELISTED
Global X Scientific Beta Asia ex-Japan ETF
SCIX
$3K ﹤0.01%
124
+100
+417% +$2.11K
PGNX
3194
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3K ﹤0.01%
600
-6,147
-91% -$47.2K
SAEX
3195
DELISTED
SAExploration Holdings, Inc.
SAEX
0
SRF
3196
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
$3K ﹤0.01%
229
+211
+1,172% +$3.82K
TSLF
3197
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$3K ﹤0.01%
178
+78
+78% +$1.28K
MFSF
3198
DELISTED
MutualFirst Financial Inc
MFSF
$3K ﹤0.01%
111
-172
-61% -$4.06K
CRCM
3199
DELISTED
CARE.COM, INC.
CRCM
$3K ﹤0.01%
600
-17,729
-97% -$104K
OTIV
3200
DELISTED
OTI On Track Innovations Ltd
OTIV
$3K ﹤0.01%
4,044
-4,158
-51% -$4.43K

Similar funds

Tower Research Capital (TRC)'s Q3 2015 Portfolio in Review

As of Q3 2015, Tower Research Capital (TRC) held 5,775 positions worth $1.03B, down 8.6% from $1.13B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC)'s Q3 2015 filing shows 1,132 new, 1,485 increased, 1,487 reduced and 1,545 closed positions. Its largest new stake was iShares Russell 2000 ETF: 144,546 shares worth $15.8M. The largest sale was VanEck Semiconductor ETF, an estimated $34M.

By sector, the portfolio is most concentrated in Financials at 2.2% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2015 buy was iShares Russell 2000 ETF: 144,546 shares worth $15.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2015, an estimated $37.1M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2015 reduction was VanEck Semiconductor ETF, cutting an estimated $34M.
  • Tower Research Capital (TRC) fully exited Vanguard Extended Market ETF in Q3 2015, selling an estimated $10M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.03B portfolio in Q3 2015.
  • Tower Research Capital (TRC) opened 1,132 new positions and closed 1,545 in Q3 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 8.6% quarter-over-quarter to $1.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.